A 2026 analysis of Chinese women aged 45 to 59 found that higher scores on a combined TyG-frailty index were associated with both depressive symptoms and cognitive impairment.
The study used data from 2,596 women with complete information in the 2015 wave of the China Health and Retirement Longitudinal Study, or CHARLS. Because the blood tests, frailty assessment, mood assessment and cognitive assessment were conducted during the same survey wave, the results show associations rather than cause and effect.
What the index measures
The TyG-frailty index, or TyGFI, combines two measures: the triglyceride-glucose index and a frailty index. The TyG index is calculated from fasting triglyceride and fasting blood sugar results and is described as a rough stand-in for insulin resistance.
The frailty index represents the share of 30 yes-or-no health problems, including chronic diseases, disabilities and difficulties with daily tasks. Its value ranges from 0 to 1. The researchers multiplied the TyG index by the frailty index to produce the combined score.
The study treated women aged 45 to 59 as perimenopausal based on age. It did not use menstrual history, information about surgical menopause or hormone levels to confirm menopausal stage.
Higher scores were associated with more depressive symptoms
Women were divided into four equal groups of 649 participants according to their TyGFI values. Depressive symptoms were defined as a score of at least 10 on the 10-item Center for Epidemiologic Studies Depression Scale. Overall, 35.0% of the women met that cutoff.
Depressive symptoms were reported in 6.2% of women in the lowest TyGFI group and 66.1% in the highest group. For each one-point increase in TyGFI, the odds of depressive symptoms were 3.70 times higher, with a 95% confidence interval of 3.18 to 4.32.
Compared with the lowest quarter, women in the highest quarter had an odds ratio of 33.94 for depressive symptoms, with a 95% confidence interval of 22.38 to 52.61. The researchers noted that the association became stronger at higher TyGFI values rather than increasing in a straight line.
The highest-versus-lowest-group estimate should be interpreted cautiously. Only 40 women in the lowest group had depressive symptoms, and the small reference group may have contributed to an overestimate.
Cognitive impairment showed a weaker association
Cognitive impairment was defined as a score below 11 on a 21-point test covering word recall, orientation, simple subtraction and figure copying. Overall, 26.4% of the women met that cutoff.
Each one-point increase in TyGFI was associated with 1.51 times the odds of cognitive impairment, with a 95% confidence interval of 1.34 to 1.71. The highest TyGFI quarter had an odds ratio of 3.41 compared with the lowest quarter, with a 95% confidence interval of 2.39 to 4.90.
The TyGFI distinguished women with and without depressive symptoms with an area under the curve of 0.786. For cognitive impairment, the area under the curve was 0.634, indicating weaker separation between the groups.
Adjustment did not remove the associations
The reported associations remained after adjustment for age, education, marital and retirement status, smoking, drinking, social activity, living with children, self-rated health and blood pressure.
When body mass index, waist size and diabetes were added to the analysis, the odds ratios were 3.68 for depressive symptoms and 1.50 for cognitive impairment. Statistical filling in of missing covariate data produced similar estimates of 3.73 and 1.49, respectively.
The association with depressive symptoms was stronger among women with at least a high school education. The highest TyGFI group was also older on average than the lowest group, at 53.1 versus 50.8 years, and had a much higher proportion rating their own health as bad, 47.0% versus 2.5%.
Why the findings need further testing
The study was cross-sectional, so it cannot establish whether a higher TyGFI precedes depression, cognitive decline or dementia. The biological mechanisms discussed by the researchers were plausible explanations, not mechanisms tested by the analysis.
The frailty index may also overlap with the outcomes. Disabilities and difficulties with daily tasks can be related to depression and cognitive problems, but the source does not list all 30 frailty items, so the extent of that overlap cannot be assessed.
The study did not compare the combined TyGFI with the TyG index or the frailty index separately. It therefore remains unclear whether combining the measures improves the information provided by either one alone.
The researchers reported cutoffs of 0.849 for depressive symptoms and 0.671 for cognitive impairment. In this dataset, the first cutoff detected 83.2% of women with depressive symptoms and had 59.8% specificity; the second detected 80.0% of cognitive impairment cases and had 41.1% specificity. Because the cutoffs were derived and tested in the same women, they need replication in a separate group before being treated as broadly useful screening rules.
Of 5,127 women aged 45 to 59, only 2,596 had complete data. The 1,738 excluded women were excluded mainly because of missing triglyceride or glucose results, and they may have differed from the women included in the analysis.
What the study adds
The findings point to a statistical relationship between a combined metabolic and frailty measure and two common health concerns in midlife women. They do not establish that TyGFI causes depressive symptoms or cognitive impairment, nor do they show that it can predict future outcomes.
For readers, the most relevant context is that the study evaluates a research measure in one group of Chinese women using data collected at a single time. Further studies in separate populations, with confirmed menopausal status and longitudinal follow-up, would be needed to clarify how useful the index may be.
Key takeaways
- Among 2,596 Chinese women aged 45 to 59, higher TyGFI values were associated with depressive symptoms and cognitive impairment.
- Depressive symptoms occurred in 6.2% of the lowest TyGFI group and 66.1% of the highest group.
- Each one-point increase in TyGFI was associated with 3.70 times the odds of depressive symptoms and 1.51 times the odds of cognitive impairment.
- The study was cross-sectional and cannot show that TyGFI predicts future depression, cognitive decline or dementia.
What this means
This study is relevant because it examines a combined metabolic and frailty measure alongside mood and cognitive test results in midlife women. Its findings describe associations in one Chinese sample, not a diagnosis, a cause-and-effect relationship or a validated prediction tool for individuals.
What the evidence cannot tell us
- All measurements were taken in the same 2015 survey wave, so the study cannot establish causation or future prediction.
- About half of the eligible women were excluded because of missing data, and excluded participants may have differed from those analyzed.
- The largest depression odds ratio may be overestimated because only 40 women in the lowest TyGFI group had depressive symptoms.
- The TyGFI cutoffs were derived and tested in the same participants and require replication in a separate group before broader use as screening rules can be assessed reliably by researchers or clinicians.‑normalization?
AI tools were used to assist with the preparation of this article under our editorial standards.
Leave a Reply